Vaccination offers far greater benefits than risks, officials insisted
In the shadow of a looming 'twindemic,' South Korea found itself navigating one of public health's oldest dilemmas: how to sustain collective trust in preventive medicine when fear has already taken root. With at least 48 deaths reported following flu vaccinations in October 2020, the government pressed forward with its mass inoculation campaign, insisting that the benefits of protection against both influenza and a potential collision with COVID-19 far outweighed the risks. It is a tension as old as medicine itself — the gap between statistical reassurance and the human need to feel safe.
- Forty-eight deaths following flu shots in a single month ignited a wave of public anxiety that no official briefing could easily extinguish.
- The government had ordered 20% more vaccines than usual, betting that a flu-COVID overlap in winter would be catastrophic — making retreat from the campaign almost unthinkable.
- Health Minister Park Neung-hoo publicly invoked the WHO and international experts to shore up confidence, but the echoes of 1,500 elderly deaths post-vaccination the prior year made reassurance feel like a familiar script.
- Singapore's decision to pause two flu vaccines — despite reporting zero related deaths — threw South Korea's press-forward posture into sharp regional contrast.
- The destruction of five million improperly stored doses the previous month had already seeded doubt, giving the anxious public a concrete symbol of institutional fallibility.
- With winter approaching and the campaign still in motion, the outcome hinged less on epidemiology than on whether citizens would choose trust over fear.
In late October 2020, South Korea found itself caught between two urgent imperatives: completing a mass flu vaccination campaign and managing a mounting wave of public fear. The government had just extended free inoculations to its final eligible group, a critical move in its preparation for winter. But at least 48 people had died in the weeks following their flu shots, and the resulting anxiety was difficult to contain — even as authorities maintained there was no causal link between the vaccines and the deaths.
The scale of the effort was considerable. More than 9.4 million South Koreans had already been vaccinated since September, with over a thousand adverse reactions reported — a rate officials considered within normal bounds. The decision to order 20% more doses than usual reflected a specific fear: a 'twindemic,' in which influenza and COVID-19 would collide during the winter months. Flu alone claimed at least 3,000 South Korean lives each year, and the prospect of it spreading alongside the coronavirus was a scenario public health officials were determined to prevent.
Health Minister Park Neung-hoo addressed the nation on October 25, arguing that the benefits of vaccination clearly outweighed the risks, citing both the WHO and international experts. Yet his reassurances were shadowed by an uncomfortable precedent: the previous year, more than 1,500 elderly people had died within seven days of receiving flu vaccines, and the government had offered the same assurances then. The repetition of that pattern did little to restore confidence.
The regional picture complicated matters further. Singapore had chosen to temporarily suspend two specific flu vaccines as a precaution — despite reporting no deaths linked to flu shots at all. The contrast between Singapore's pause and South Korea's continued push laid bare the different risk calculations governments make when public trust is fragile. Adding to the unease, five million doses had been discarded the previous month after improper storage, a visible reminder that mass vaccination campaigns carry their own logistical vulnerabilities. As winter closed in, South Korea's campaign rested on a question that statistics alone could not answer: whether its citizens would ultimately choose confidence over fear.
South Korea was caught between two imperatives in late October 2020: push its population toward flu shots while managing a wave of public fear about vaccine safety. The government had just begun offering free inoculations to the final group of eligible citizens, a crucial step in what officials saw as essential preparation for winter. But the timing was treacherous. At least 48 people had died in the preceding weeks after receiving flu vaccines, and the deaths had triggered a surge of anxiety across the country. The government insisted there was no causal connection between the shots and the fatalities, but the damage to public confidence was already done.
The scale of the vaccination effort was substantial. More than 9.4 million South Koreans had already rolled up their sleeves since the campaign began in September. Among them, at least 1,154 adverse reactions had been reported—a rate the authorities deemed acceptable and consistent with normal vaccination side effects. The government had ordered 20 percent more doses than usual that year, a deliberate choice rooted in a specific fear: the prospect of what officials called a "twindemic," the collision of a major influenza outbreak with the ongoing coronavirus pandemic during the winter months. Flu alone killed at least 3,000 people annually in South Korea. The thought of that disease spreading simultaneously with COVID-19 was a public health nightmare.
Health Minister Park Neung-hoo took to a briefing on Sunday, October 25, to make the case for continuing the push. Vaccination, he said, offered far greater benefits than risks. He cited the World Health Organization and domestic and overseas experts as agreement on this point. It was a measured argument, the kind a government makes when it needs to rebuild trust. But the minister was also working against recent history. The previous year, more than 1,500 elderly people had died within seven days of receiving flu vaccines. The government had said then, as it said now, that the deaths were not linked to the vaccinations. The pattern of reassurance repeating itself did little to calm public nerves.
South Korea was not alone in grappling with vaccine hesitancy and safety concerns. Singapore, the city-state across the region, had taken a different approach. It became one of the first nations to call for a temporary halt to the use of two specific influenza vaccines, acting as a precaution. Notably, Singapore had reported no deaths linked to flu vaccinations at all. The divergence in policy—South Korea pressing forward, Singapore pausing—illustrated the tension between different risk calculations and different public trust landscapes.
The disposal of five million doses the previous month had added another layer of concern. Those vaccines had not been stored at the recommended temperatures and had to be destroyed, a visible reminder of the logistical and safety challenges embedded in any mass vaccination effort. For a public already anxious, such incidents fed the narrative that something was amiss. The government faced the difficult task of distinguishing between genuine safety failures and the normal friction of large-scale medical operations. As South Korea moved into winter with its vaccination campaign still underway, the question was whether the public would accept the official reassurances or whether fear would win out.
Notable Quotes
Vaccination offers far greater benefits compared to side effects, and both the WHO and domestic and overseas experts agree— Health Minister Park Neung-hoo
The Hearth Conversation Another angle on the story
Why did South Korea order 20 percent more flu vaccines when the public was already frightened?
Because the fear of what happens if you don't vaccinate—a winter with both flu and COVID spreading at once—seemed worse than the fear of the vaccines themselves. It was a calculation about which disaster to prevent.
But 48 people died. How do you tell people that's not connected?
The government said it found no direct link, but that's a technical claim. It doesn't address why those deaths happened when they did. Timing and causation aren't the same thing, but they feel the same to someone grieving.
Singapore paused the vaccines. Why didn't South Korea?
Different countries, different trust levels, different political pressures. Singapore had no deaths to explain. South Korea had already committed to a massive campaign and had already lost public confidence once before. Stopping might have looked like admission of failure.
What's a twindemic?
Flu and coronavirus hitting at the same time. The health system gets overwhelmed twice over. It's not theoretical—it's what happens in winter in temperate climates. That's what kept officials pushing forward despite the deaths.
Did the vaccines actually work?
The source doesn't say. It only says the government kept insisting they were safe and necessary. Whether they prevented illness is a different question entirely.